Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
2000000 participants
OBSERVATIONAL
2024-10-31
2034-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases
NCT05334940
Markers of Atopy in Children With Presumed Early Exposure to Allergens, Unhygienic Conditions, and Infections
NCT00503048
Montelukast as a Controller of Atopic Syndrome
NCT00559546
The Effects of Immunotherapy in the Nose
NCT01985542
Biodiversity Intervention and Atopic Sensitization
NCT03872219
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
OTHER
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
No intervention
No intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Professor Lauri Lehtimäki
UNKNOWN
Professor Mika Mäkelä
UNKNOWN
Professor Sanna Toppila-Salmi
UNKNOWN
Professor Ilkka Junttila
UNKNOWN
Tampere University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Peter Csonka
MD, PhD, Associate professor of pediatrics
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Péter Csonka
Role: PRINCIPAL_INVESTIGATOR
Tampere University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tampere University
Tampere, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
FinnATOPY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.